Cargando…
Toll-Like Receptors and Relevant Emerging Therapeutics with Reference to Delivery Methods
The built-in innate immunity in the human body combats various diseases and their causative agents. One of the components of this system is Toll-like receptors (TLRs), which recognize structurally conserved molecules derived from microbes and/or endogenous molecules. Nonetheless, under certain condi...
Autores principales: | Javaid, Nasir, Yasmeen, Farzana, Choi, Sangdun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6781272/ https://www.ncbi.nlm.nih.gov/pubmed/31480568 http://dx.doi.org/10.3390/pharmaceutics11090441 |
Ejemplares similares
-
Toll-like Receptors from the Perspective of Cancer Treatment
por: Javaid, Nasir, et al.
Publicado: (2020) -
Therapeutic Interventions into Innate Immune Diseases by Means of Aptamers
por: Yasmeen, Farzana, et al.
Publicado: (2020) -
The Roles of the NLRP3 Inflammasome in Neurodegenerative and Metabolic Diseases and in Relevant Advanced Therapeutic Interventions
por: Pirzada, Rameez Hassan, et al.
Publicado: (2020) -
Recent clinical trends in Toll‐like receptor targeting therapeutics
por: Anwar, Muhammad Ayaz, et al.
Publicado: (2018) -
Therapeutic Applications of Nucleic Acids and Their Analogues in Toll-like Receptor Signaling
por: Gosu, Vijayakumar, et al.
Publicado: (2012)